Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Pegylated Interferon Alfa-2a (PEG-IFN Alfa)	25
Overall Study	STARTED	Bulevirtide 2 mg/Day + PEG-IFN Alfa	50
Overall Study	STARTED	Bulevirtide 10 mg/Day + PEG-IFN Alfa	50
Overall Study	STARTED	Bulevirtide 10 mg/Day	50
Overall Study	COMPLETED	Pegylated Interferon Alfa-2a (PEG-IFN Alfa)	17
Overall Study	COMPLETED	Bulevirtide 2 mg/Day + PEG-IFN Alfa	38
Overall Study	COMPLETED	Bulevirtide 10 mg/Day + PEG-IFN Alfa	45
Overall Study	COMPLETED	Bulevirtide 10 mg/Day	45
Overall Study	NOT COMPLETED	Pegylated Interferon Alfa-2a (PEG-IFN Alfa)	8
Overall Study	NOT COMPLETED	Bulevirtide 2 mg/Day + PEG-IFN Alfa	12
Overall Study	NOT COMPLETED	Bulevirtide 10 mg/Day + PEG-IFN Alfa	5
Overall Study	NOT COMPLETED	Bulevirtide 10 mg/Day	5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03852433/flow